Drug of Abuse Testing Market Size to Reach US$ 9.15 Bn by 2032
by The global drug of abuse testing market size was valued at US$ 4.90 billion in 2022 and is projected to hit US$ 9.15 billion by …
Category: Drug Development
Asthma Drugs Market Size to Hit US$ 34.28 Bn by 2030
The global asthma drugs market is predicted to reach over USD 34.28 billion by 2030, growing at a CAGR of 5.2% during the forecast period …
Generic Sterile Injectable Market Size to Reach US$ 203.66 Bn by 2030
The global generic sterile injectable market size was valuedat US$ 77.41 billion in 2021 and is expected to reach US$ 203.66 billion by 2030, growing at …
Enteral Feeding Devices: Valuable Niche in Medical Devices
Due to the COVID-19 pandemic, it has been assessed that the major stake of the medical devices business that comprises dental care devices, imaging devices, …
Electrophysiology Devices Market Size to Grow USD 10.72 Billion By 2030
The global electrophysiology devices market is projected to hit around USD 10.72 billion by 2027 with a remarkable CAGR of 8.6% from 2022 to 2027. …
AI Integration Push by Governments and Research Institutes to Transform Quality of Care for Cardiac Patients
Integration of artificial intelligence (AI) is picking up pace in drug development. AI is used for various aspects, starting from the discovery of compounds exhibiting …
AstraZeneca and BenevolentAI Completes Third Milestone in Their AI-Enabled Drug Discovery Cooperation
AstraZeneca has identified an additional novel target for its drug development portfolio for idiopathic pulmonary fibrosis (IPF), allowing BenevolentAI, a leading clinical-stage AI-enabled drug discovery …
NanoViricides Begins Drug Development to Combat Severe Pediatric Hepatitis
NanoViricides, Inc., a frontrunner in the development of antiviral therapies based on a novel platform of nanomedicines has reported to have begun drug development to …
FDA Encouraging Novel Drug Development for Crohn’s Disease and Ulcerative Colitis
The US Food and Drug Administration (FDA) recently released draught guidance documents on drug development for ulcerative colitis (UC) and Crohn’s disease, which include clinical …
USFDA Approves Lupin’s Generic Equivalent to Pregabalin Capsules
A recent announcement by Mumbai based drug manufacturer, Lupin states that they have bagged approval from USFDA – the United States Food and Drug Administration, …